LONG LASTING EFFECT OF NEW BOTULINUM TOXIN FORMULATIONS
Publication
EP3845241A1
Kind: A1
Mar 18, 2026
Applicants
Medy-Tox, Inc.
Inventors
Jung, Hyun Ho, Yang, Gi Hyeok, Kim, Hyun Jee, Rhee, Chang Hoon
Abstract
The invention relates to the use of an animal-protein-free botulinum toxin composition to treat a disease, disorder or condition in a patient in need thereof whereby the animal-protein-free botulinum toxin composition exhibits a longer lasting effect in the patient compared to an animal-protein-containing botulinum toxin composition.
IPC Classifications
A61K 38/48 20060101AFI20210527BHEP
A61K 8/64 20060101ALI20210527BHEP
A61P 17/00 20060101ALI20210527BHEP
A61P 21/02 20060101ALI20210527BHEP
A61P 25/06 20060101ALI20210527BHEP
A61P 25/24 20060101ALI20210527BHEP
A61K 9/19 20060101ALI20210527BHEP
A61Q 19/08 20060101ALI20210527BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR